BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11378539)

  • 21. Therapy-related malignancies following treatment of germ cell cancer.
    Kollmannsberger C; Hartmann JT; Kanz L; Bokemeyer C
    Int J Cancer; 1999 Dec; 83(6):860-3. PubMed ID: 10597212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence and characterization of secondary myelodysplastic syndromes following autologous transplantation.
    Del Cañizo Mf; Amigo Mf; Hernández JM; Sanz G; Núñez R; Carreras E; Alegre A; Cuesta B; Mataix R
    Haematologica; 2000 Apr; 85(4):403-9. PubMed ID: 10756367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangements.
    Andersen MK; Johansson B; Larsen SO; Pedersen-Bjergaard J
    Haematologica; 1998 Jun; 83(6):483-8. PubMed ID: 9676019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors?
    Dissing M; Le Beau MM; Pedersen-Bjergaard J
    J Clin Oncol; 1998 May; 16(5):1890-6. PubMed ID: 9586906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation.
    Pedersen-Bjergaard J; Rowley JD
    Blood; 1994 May; 83(10):2780-6. PubMed ID: 8180374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV).
    Wheeler C; Khurshid A; Ibrahim J; Elias A; Mauch P; Ault K; Antin J
    Leuk Lymphoma; 2001 Feb; 40(5-6):499-509. PubMed ID: 11426523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure.
    Levine EG; Bloomfield CD
    Semin Oncol; 1992 Feb; 19(1):47-84. PubMed ID: 1736370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapy-related acute leukemia: study of 23 pacients].
    Motlló C; Sancho JM; García O; Granada I; Millá F; Ribera JM
    Med Clin (Barc); 2011 Oct; 137(10):449-52. PubMed ID: 21696789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias.
    Fianchi L; Pagano L; Piciocchi A; Candoni A; Gaidano G; Breccia M; Criscuolo M; Specchia G; Maria Pogliani E; Maurillo L; Aloe-Spiriti MA; Mecucci C; Niscola P; Rossetti E; Mansueto G; Rondoni M; Fozza C; Invernizzi R; Spadea A; Fenu S; Buda G; Gobbi M; Fabiani E; Sica S; Hohaus S; Leone G; Voso MT
    Am J Hematol; 2015 May; 90(5):E80-5. PubMed ID: 25653205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Secondary leukemia after chemotherapy and/or radiotherapy for gynecologic neoplasia.
    Shimada T; Saito T; Okadome M; Shimamoto K; Ariyoshi K; Eto T; Tomita Y; Kodama K
    Int J Gynecol Cancer; 2014 Feb; 24(2):178-83. PubMed ID: 24407580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapy-related acute myeloid leukemia and myelodysplasia after successful treatment of acute promyelocytic leukemia.
    Zompi S; Viguié F
    Leuk Lymphoma; 2002 Feb; 43(2):275-80. PubMed ID: 11999558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case of treatment-related myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemotherapy with autologous stem cell transplantation for non-Hodgkin's lymphoma.
    Jang GD; Kim SW; Suh CW; Kim EK; Bahng HS; Jeong YH; Park IG; Kim WK; Kim SH; Suh EJ; Park CJ; Ji HS; Lee JS
    J Korean Med Sci; 2002 Aug; 17(4):555-9. PubMed ID: 12172056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer.
    Pedersen-Bjergaard J; Sigsgaard TC; Nielsen D; Gjedde SB; Philip P; Hansen M; Larsen SO; Rørth M; Mouridsen H; Dombernowsky P
    J Clin Oncol; 1992 Sep; 10(9):1444-51. PubMed ID: 1517787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High frequency of pro-B acute lymphoblastic leukemia in adults with secondary leukemia with 11q23 abnormalities.
    Ishizawa S; Slovak ML; Popplewell L; Bedell V; Wrede JE; Carter NH; Snyder DS; Arber DA
    Leukemia; 2003 Jun; 17(6):1091-5. PubMed ID: 12764373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Secondary leukemias: their clinical features, incidence among populations at risk, mechanisms and new strategy for prediction].
    Abe T
    Gan To Kagaku Ryoho; 1999 Nov; 26(13):1999-2008. PubMed ID: 10584563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
    Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC
    Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secondary myelodysplastic syndromes and leukemias.
    Giles FJ; Koeffler HP
    Curr Opin Hematol; 1994 Jul; 1(4):256-60. PubMed ID: 9371291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment-related myelodysplasia and acute leukemia in non-Hodgkin's lymphoma patients.
    Armitage JO; Carbone PP; Connors JM; Levine A; Bennett JM; Kroll S
    J Clin Oncol; 2003 Mar; 21(5):897-906. PubMed ID: 12610191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is age an independent risk factor for chemically induced acute myelogenous leukemia in children?
    Pyatt DW; Aylward LL; Hays SM
    J Toxicol Environ Health B Crit Rev; 2007; 10(5):379-400. PubMed ID: 17687725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapy-related acute myelogenous leukemia associated with 11q23 chromosomal abnormalities and topoisomerase II inhibitors: report of four additional cases and brief commentary.
    Bredeson CN; Barnett MJ; Horsman DE; Dalal BI; Ragaz J; Phillips GL
    Leuk Lymphoma; 1993 Sep; 11(1-2):141-5. PubMed ID: 8220147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.